The U.S. Pharmacopeia (Rockville, MD) opened a new, 1800-sq-meter facility in the Wtorre Technology Park in Sao Paulo, Brazil, on August 18. The facility, situated close to several of USP’s pharmaceutical clients, contains state-of-the-art office and laboratory space that the organization will use to dispense its publications and reference standards to local manufacturers.
The U.S. Pharmacopeia (Rockville, MD) opened a new, 1800-sq-meter facility in the Wtorre Technology Park in Sao Paulo, Brazil, on August 18.
The facility, situated close to several of USP’s pharmaceutical clients, contains state-of-the-art office and laboratory space that the organization will use to dispense its publications and reference standards to local manufacturers.
“This new site demonstrates USP’s commitment to ensuring the quality and safety of pharmaceuticals, dietary supplements, and food ingredients for everyone, regardless of geographic, economic, or political borders,” said USP executive vice president and CEO Roger Williams, MD. “As the world continues to focus on these issues, it is even more important for standard-setting bodies and governments to collaborate. This office and laboratory facility will help USP work with Brazilian regulators and manufacturers to move toward that goal.”
Flavio Vormittag, MD, vice president of USP Brazil, added that the company will work closely with the National Health Surveillance Agency (Brasilia, Brazil), the Brazilian Federation of the Pharmaceutical Industry (Brasilia, Brazil), and other organizations to ensure the quality of medicines and food ingredients.
“Our presence will benefit Brazilian manufacturers, government agencies, and ultimately patients in Brazil, the United States, and the many countries to which Brazil exports,” Vormittag said.
Brightseed launches clinically validated ingredient, Bio Gut Core, to support gut barrier function
May 21st 2025The low-dose, easy-to-formulate ingredient is a proprietary blend of two bioactives – N-trans caffeoyltyramine (NCT) and N-trans feruloyltyramine (NFT) – which were discovered by the company’s Forage AI platform.
The Nutritional Outlook Podcast Episode 39: Nutritional Outlook's Ingredients to Watch in 2025
February 25th 2025In this episode, Nutritional Outlook interviews Scott Dicker, market insights director from market researcher SPINS, about ingredients and product categories nutraceutical and nutrition product manufacturers should watch in 2025.